Essay

Commercial beneficiaries should share costs

Michael  Malamy
By Michael Malamy
November 01, 2018

It has long been established that the benefits of research funded by the National Institutes of Health flow freely to academic and commercial enterprises and ultimately to the general public whose taxes have funded the research. It is now evident that because of limitations of the NIH budget, many meritorious grant applications are not being funded. The negative results of this funding crunch have been widespread; not only has important research into vital issues of disease causality and treatment been delayed, but the research infrastructure in manpower has been seriously compromised. Long-productive labs have been closed, established scientists no longer participate in research, and most importantly, graduate students and young professors are being persuaded that academic research is not a viable career choice.

Congress and the American public have been generous in supporting research in basic and applied medical sciences, but this support has not kept up with the explosion in knowledge that now presents the opportunity to approach and solve some of the fundamental problems in medicine. A new model is needed for supplementing the NIH budget with additional funding not derived from the federal budget. I am suggesting that some of the costs be shared by those commercial interests that benefit from NIH-funded research.

The “wool tax” in Australia is one model for this type of research funding support. A certain percentage of revenue from the wool industry is set aside to support research that could impact the wool industry; this could be basic research in animal husbandry or diseases of sheep, but the tax also has funded basic research in protein chemistry of wool proteins.

Another possible model would be to impose a license fee and royalty structure on companies that use NIH-funded basic or applied research findings in their product development. Commercial support of NIH funding could be offset by tax credits for the participating companies, thus reducing the direct costs to these companies.

Many other equitable models could be proposed, but the governing principle should be that companies that benefit from NIH-supported applied or basic research compensate the sources of these discoveries.

Michael  Malamy
Michael Malamy

Michael Malamy is a senior tenured faculty member at Tufts University School of Medicine.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Policy

Policy highlights or most popular articles

Still unclear why university expelled 15 Chinese researchers
Blotter

Still unclear why university expelled 15 Chinese researchers

September 23, 2020

The University of North Texas has said only that the decision followed briefings by federal and local law enforcement.

ASBMB joins amicus brief
Blotter

ASBMB joins amicus brief

August 26, 2020

Society and other nonprofits raise concerns about racial profiling by federal investigators and prosecutors’ attempts to criminalize administrative errors.

Science-related legislation to watch
Blotter

Science-related legislation to watch

August 19, 2020

One bill would provide $26 billion in emergency funding for agencies that support research; another would protect against foreign influence in research.

We are here because we choose to be
Editorial

We are here because we choose to be

July 23, 2020

Five months into a pandemic with arguably the world’s worst response, the United States can no longer take the easy way out and blame only politics for our downfall. We’re to blame, too.

NSF foreign influence probes net nearly two dozen
Blotter

NSF foreign influence probes net nearly two dozen

July 15, 2020

Meanwhile, feds charge Ohio State researcher with fraud and drop theft charges against Emory professor.

U.S. seeks to kick out and ban foreign students
Blotter

U.S. seeks to kick out and ban foreign students

July 08, 2020

Harvard and MIT sue government to stop rule change targeting F-1 and M-1 visa holders at or heading to institutions offering only online courses this fall because of COVID-19.